NCT00648882View on ClinicalTrials.gov

Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2007

Conditions
Healthy
Interventions
DRUG

LEVOTHYROXINE SODIUM TABLETS,

2x300mcg, single dose fasting

DRUG

SYNTHROID® 300 mcg Tablets

2x300mcg, single dose fasting

Trial Locations (1)

58104

PRACS Institute Ltd. - Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY